By Jessica Dacey An executive at Swiss group Novartis has been appointed to a World Health Organization body advising on research despite criticism it may lead to a conflict of interest. Paul Herrling, the Swiss head of corporate research at pharmaceutical concern Novartis, was among 21 people approved this week to join a WHO expert […]
SaneVax Introduces One More Cervarix Girl: Lara from Wales
By Norma Erickson, President of SaneVax Inc. Lara’s story is but another in the line of tragedies following GlaxoSmithKline’s “Armed for Life” marketing campaign for Cervarix. Prior to Cervarix, Lara was every mother’s dream child. She didn’t cry, finished her bottles in the blink of an eye and was always smiling. As she grew, […]
EpiVax receives $458,000 NIH grant to develop universal influenza vaccine
By PBN staff PROVIDENCE – EpiVax Inc. said Tuesday it has received a $458,000, two-year grant to develop a universal influenza vaccine. “There is an urgent, unmet need for an influenza vaccine with greater potency and wider application to diverse flu viruses that can also be developed more rapidly than conventional influenza vaccines,” said Dr. […]
False Advertising of the HPV Vaccines
By Christina England 19 January 2011 A recent news report claims that there has been a spate of false advertising by Merck and GlaxoSmithKline for their HPV vaccines. SANE VAX sent out a press release this week reporting that around the world HPV vaccines have been falsely advertised. They state that as a consequence of […]
January 13, 2011 FDA Approval Letter – Cervarix
Our STN: BL 125259/112 GlaxoSmithKline Biologicals Attention: Matthew Whitman 2301 Renaissance Boulevard P.O. Box 61540 King of Prussia, PA 19406-2772 Dear Mr. Whitman: We have approved your request to supplement your biologics license application for Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant, to include a Patient Package Insert to the full prescribing information. […]
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 57
- Next Page »
